Results 211 to 220 of about 149,982 (306)

Prognostic value of estimating serum proteins in cases of ulcerative colitis in remission.

, 1969
F T de Dombal
openalex   +1 more source

Synchronous Melanoma: A Single‐Centre 5‐Year Retrospective Study

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Synchronous melanoma (SM) is defined as ≥ 2 melanomas diagnosed at the same time, or within 3 months of diagnosing the first melanoma, and occurs rarely. Objectives The objective of this study was to review all the cases of SM discussed at the melanoma MDT meeting in our cancer centre over the last 5 years.
Ji Fung Yong, Michael O'Connell, Alana Durack, Lyndsey Paul   +3 more
wiley   +1 more source

Radiomics prediction of surgery in ulcerative colitis refractory to medical treatment. [PDF]

Tech Coloproctol
Sakamoto K, Okabayashi K, Seishima R, Shigeta K, Kiyohara H, Mikami Y, Kanai T, Kitagawa Y.   +7 more
europepmc   +1 more source

Concomitant Graves' Disease and Ulcerative Colitis. [PDF]

Cureus
Webeler P, Abdollahi Zarandi P, Bashyam M.   +2 more
europepmc   +1 more source

Investigating the Impact of hsa_circ_0005255 on Proliferation and Autophagy in Crohn's Disease Intestinal Epithelial Cells Through miR‐23a‐3p‐Mediated NCOA3 Expression

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Crohn's Disease (CD), an inflammatory bowel disorder, is influenced by genetic, immune, and environmental factors. The present study highlights the pioneering role of circular RNAs (circRNAs) in the etiology of CD, with a specific focus on hsa_circ_0005255 and its regulatory role.
Dong Liu, De‐Run Kong
wiley   +1 more source

Astragaloside IV Alleviates Ulcerative Colitis Progression by Inhibiting WDR5‐Mediated ENO1 H3K4me3 Modification

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Ulcerative colitis (UC) has become a prevalent global health concern. This study scrutinized the influence of Astragaloside IV (ASI) on DSS‐induced UC, with particular emphasis on the role of WDR5 in mediating ENO1 expression. The therapeutic efficacy of ASI was assessed in a mouse model of UC by evaluating disease activity index, pathology ...
Su‐Xiao Wu, Zi‐Lan Chen, Xiao‐Hong Wang, Jie Gu   +3 more
wiley   +1 more source

Serum Periostin is Able to Stratify Type 2-Dominant Ulcerative Colitis. [PDF]

Inflamm Bowel Dis
Takedomi H, Nunomura S, Nanri Y, Honda Y, Yokomizo K, Akutagawa T, Tsuruoka N, Sakata Y, Conway S, Kawaguchi A, Aishima S, Esaki M, Izuhara K.   +12 more
europepmc   +1 more source

Antithrombin: Deficiency, Diversity, and the Future of Diagnostics

Mass Spectrometry Reviews, EarlyView.
ABSTRACT Our healthcare system provides reactive sick‐care, treating patients after symptoms have appeared by prescription of generic and often suboptimal therapy. This strategy brings along high costs and high pressure which is not sustainable.
Mirjam Kruijt, Christa M. Cobbaert, L. Renee Ruhaak   +2 more
wiley   +1 more source

Evidence for a Modulatory Effect of a 12‐Week Pomegranate Juice Intervention on the Transcriptional Response in Inflammatory Bowel Disease Patients Reducing Fecal Calprotectin Levels: Findings From a Proof‐of‐Principle Study

Molecular Nutrition &Food Research, EarlyView.
This study investigated how pomegranate juice affects inflammation in patients with inflammatory bowel disease who are currently in remission. After 12 weeks of drinking pomegranate juice, patients showed reduced markers of intestinal inflammation.
Ilaria Minato, Pedro Mena, Luigi Ricciardiello, Eleonora Scaioli, Andrea Belluzzi, Enrica Rotondo, Eleonora Derlindati, Barbara Montanini, Costanza Michelini, Nicole Tosi, Vicente Agullò Garcià, Gianfranco Picone, Carlo Mengucci, Sara Dobani, Paloma Salamanca, Alice Rosi, Margherita Dall'Asta, Letizia Bresciani, Claudio Curti, Enzo Spisni, Alessandra Dei Cas, Alessandra Bordoni, Francisco A. Tomás‐Barberán, Lynnette R. Ferguson, Daniele Del Rio, Francesca Danesi   +25 more
wiley   +1 more source

Golimumab-induced lichen planus pigmentosus in a patient with ulcerative colitis. [PDF]

An Bras Dermatol
Alfaro-Sepúlveda D, Escanilla C, Valenzuela F, Peirano D.   +3 more
europepmc   +1 more source